Showing 41 - 60 results of 64 for search '"European studies"', query time: 0.09s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47

    Remarks and advice to the study of early arthropod succession near melting glaciers by Sigmund Hågvar, Barbara Valle, Mauro Gobbi

    Published 2024-12-01
    “…We present remarks and advice on this topic, using examples from European studies. We explore the driving forces supporting the early ecosystem, discuss the ability of certain micro- and macroarthropods to be pioneers, and highlight the autecology of pioneer species and their role in building early trophic networks. …”
    Get full text
    Article
  8. 48
  9. 49

    Epidemiology of Acute Pancreatitis in the North Adriatic Region of Croatia during the Last Ten Years by Davor Stimac, Ivana Mikolasevic, Irena Krznaric-Zrnic, Mladen Radic, Sandra Milic

    Published 2013-01-01
    “…Introduction. Several European studies have reported an increase in the incidence rate of acute pancreatitis (AP). …”
    Get full text
    Article
  10. 50

    Psychological distress during the first phase of the COVID-19 pandemic in Ecuador: Cross-sectional study. by Juan Gómez-Salgado, Ingrid Adanaque-Bravo, Mónica Ortega-Moreno, Regina Allande-Cussó, Cristian Arturo Arias-Ulloa, Carlos Ruiz-Frutos

    Published 2021-01-01
    “…Differences have been observed with European studies regarding common symptoms, preventive measures to avoid contagion, percentage of infected relatives, or diagnostic tests performed.…”
    Get full text
    Article
  11. 51
  12. 52

    Response of Pedunculate Oak (<i>Quercus robur</i> L.) to Adverse Environmental Conditions in Genetic and Dendrochronological Studies by Konstantin V. Krutovsky, Anna A. Popova, Igor A. Yakovlev, Yulai A. Yanbaev, Sergey M. Matveev

    Published 2025-01-01
    “…We tried to include the most relevant, important, and significant studies, but focused mainly on the relatively recent Eastern European studies because they include the most of the species’ area. …”
    Get full text
    Article
  13. 53
  14. 54
  15. 55
  16. 56

    Genomic epidemiology of third-generation cephalosporin-resistant Escherichia coli from companion animals and human infections in Europe by Adrien Biguenet, Benoit Valot, Farid El Garch, Xavier Bertrand, Didier Hocquet

    Published 2025-06-01
    “…The aim of this study was to compare the genomes of third-generation cephalosporin-resistant (3GC-R) Escherichia coli responsible for human and pet infections in Europe.Whole-genome sequencing data from 3GC-R E. coli isolated from clinical samples of humans, dogs and cats, and published in eight European studies were re-analyzed using bioinformatics tools. …”
    Get full text
    Article
  17. 57

    Retrospective Analysis of the Prevalence and Risk Factors of Retinopathy of Prematurity in a Single-Center Cohort in Romania and Comparison with National and European Data by Zsuzsánna Simon-Szabó, Sándor Pál, Aliz Pándi, Zsuzsanna Gáll, Hajnal Finta, Zsuzsánna Incze-Bartha, Cristina Maki, Manuela Cucerea

    Published 2025-01-01
    “…The variations in GA thresholds (32 vs. 34 weeks) between studies required stratified analyses to ensure meaningful comparisons. The included European studies provided data on screening criteria, prevalence, and associated risk factors, offering a comprehensive perspective on screening effectiveness. …”
    Get full text
    Article
  18. 58

    A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsResearch in context by Yuji Hiromatsu, Eri Ishikawa, Ai Kozaki, Yasuhiro Takahashi, Mika Tanabe, Ken Hayashi, Yukihiro Imagawa, Kazutoyo Kaneda, Masashi Mimura, Xiaoxian Dai, Tomoko Hayashida, Takashi Akamizu

    Published 2025-02-01
    “…Summary: Background: Teprotumumab significantly improved proptosis and diplopia in patients with active, moderate-to-severe thyroid eye disease (TED) in previous North American and European studies. This is the first evaluation of efficacy and safety of teprotumumab for active, moderate-to-severe TED in Japanese patients. …”
    Get full text
    Article
  19. 59
  20. 60